OptimizeRx (OPRX) Depreciation & Amortization (CF) (2010 - 2026)

OptimizeRx has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $1.1 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 0.93% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $4.3 million (down 1.63% YoY), while the FY2025 annual figure was $4.3 million, changed 0.05% from the prior year.
• Depreciation & Amortization (CF) came in at $1.1 million for Q2 2026 at OptimizeRx, roughly flat from $1.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q3 2024 to a low of $456545.0 in Q4 2022.
• Average Depreciation & Amortization (CF) over 5 years is $844890.5, with a median of $1.1 million recorded in 2026.
• Year-over-year, Depreciation & Amortization (CF) decreased 19.57% in 2023 and jumped 134.48% in 2024.
• Over 5 years, Depreciation & Amortization (CF) stood at $456545.0 in 2022, then surged by 120.57% to $1.0 million in 2023, then advanced by 8.64% to $1.1 million in 2024, then declined by 1.46% to $1.1 million in 2025, then slipped by 1.3% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.1 million in Q2 2026, $1.1 million in Q1 2026, and $1.1 million in Q4 2025.